Key result
Serum sP-selectin levels were higher in patients with saphenous vein graft stenosis, with levels >57.5 ng/ml yielding 73.3% sensitivity.
Why the study?
Are serum levels of solubilized adhesion molecules associated with late aortocoronary saphenous vein graft stenosis?
Case-Control (n=84)
Are serum levels of solubilized adhesion molecules associated with late aortocoronary saphenous vein graft stenosis?
Elevated serum sP-selectin levels are independently associated with late saphenous vein graft stenosis, suggesting a potential role for platelet activation in late graft disease.
Answers are grounded in this paper and cite their sources.
May flag late vein graft stenosis risk; leaves open predictive value and need for prospective validation before clinical use.
In Brief Objective To assess the diagnostic importance of serum-solubilized adhesion molecules, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, sE-selectin and sP-selectin in aortocoronary saphenous vein graft disease. Methods The study population was composed of two groups consisting of 41 patients with saphenous vein graft stenosis (stenosis group) and 43 patients without saphenous vein graft stenosis (no-stenosis group) based on the results of coronary angiography. All patients underwent coronary artery bypass graft operation involving the use of at least one saphenous vein graft for bypass. At the time of cardiac catheterization, it had been more than 1 year since the operation. Results Serum level of sP-selectin was significantly higher in the stenosis group than in the no-stenosis group (72.9±21.7 versus 48.7±18.6 ng/ml, P<0.001). No differences were found between the two groups with respect to serum levels of sE-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Multivariate analysis revealed that only serum levels of sP-selectin, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were independently correlated with the stenosis of saphenous vein grafts. A cutoff value of serum sP-selectin >57.5 ng/ml yields a specificity of 79.5%, a sensitivity of 73.3% and a positive predictive value of 80.5% for saphenous vein graft stenosis. Conclusion In this study, sP-selectin level was found to be significantly higher in the group that had late aortocoronary saphenous vein bypass graft disease. This result suggests that platelet activation may play a causal role in late graft disease. We aimed to assess the diagnostic importance of serum solubilized adhesion molecules, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, sE-selectin and sP-selectin in aortocoronary saphenous vein graft disease. The study population was composed of two groups consisting of 41 patients with saphenous vein graft stenosis and 43 patients without saphenous vein graft stenosis based on the results of coronary angiography. At the time of cardiac catheterization, it had been more than 1 year since the operation. Serum level of sP-selectin was significantly higher in the stenosis group than in the no-stenosis group. No differences were found between the two groups with respect to serum levels of sE-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Multivariate analysis revealed that only serum levels of sP-selectin, HDL cholesterol and LDL cholesterol were independently correlated with the stenosis of saphenous vein grafts. This study suggests that platelet activation may play a causal role in late graft disease.
No takes yet. Share an insight, caveat, or question.
Aras et al. (2005) conducted a case-control in Aortocoronary saphenous vein graft disease (n=84). Saphenous vein graft stenosis vs. No saphenous vein graft stenosis was evaluated on Serum sP-selectin level (ng/ml) (p=<0.001). Serum sP-selectin levels were higher in patients with saphenous vein graft stenosis, with levels >57.5 ng/ml yielding 73.3% sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: